The DOI matches its Crossref record; 57 of the 71 references it cites were found in a registry or an index.
DNA damage induces phosphorylation of the amino terminus of p53
Open accessAbstract
Data are presented demonstrating that DNA damage leads to specific post-translational modifications of p53 protein. Using two-dimensional peptide mapping of in vivo radiolabeled p53 tryptic phosphopeptides, recombinant truncated p53 protein, and synthetic p53 tryptic peptides, a unique p53 phosphopeptide was identified after exposure of ML-1 cells to ionizing irradiation. This peptide represents the first 24 amino acids of p53 and contains three phosphorylated serine residues. A specific p53 phosphopeptide antibody identified serine-15 as one of the two serines in p53 that becomes phosphorylated following DNA damage induced by either ionizing irradiation (IR) or ultraviolet (UV) irradiation in multiple cell types. IR-induced phosphorylation of p53 does not affect the kinetics of p53 binding to or dissociating from DNA as assessed by electrophoretic mobility-shift assays. However, p53 phosphorylation induced by DNA damage correlates with enhanced transcription of downstream p53 target genes. Low levels of phosphoserine-15 p53 are detectable within 6 hr after IR in AT cells, whereas lymphoblasts from normal individuals exhibit this modification within 1 hr. In contrast, phosphorylation of p53 on serine-15 is similar in normal and AT cells after UV irradiation. Our results indicate that p53 is phosphorylated in response to DNA damage, that this de novo phosphorylation may be involved in the subsequent induction and activation of p53, and that although ATM affects the kinetics of p53 phosphorylation after IR, it is not absolutely required for phosphorylation of p53 on serine-15.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Doxorubicin treatment of early passage tumor cell lines revealed that five of five early generation mTerc Ink4a / Arf -/ -tumors maintained intact p53 response evidenced by p53 Ser-18 phosphorylation (37, 38) and associated induction of p21 CIP1 .”
From Ink4a / Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [38]
Experimental — accuracy not yet measuredIn the citing paper
“Induction of double strand breaks in DNA by ionizing radiation or genotoxic chemotherapy leads to the rapid stabilization of p53 through phosphorylation of its N terminus (Shieh et al. 1997; Siliciano et al. 1997”
From p53 Deficiency Rescues the Adverse Effects of Telomere Loss and Cooperates with Telomere Dysfunction to Accelerate Carcinogenesis (1999) · cites this paper as Siliciano et al. 1997
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 3,761
Self-citationRegulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 1×
“It has been demonstrated recently that the mechanism for this inhibition involves binding Mdm2 to p53 and targeting p53 for rapid degradation (Haupt et al. 1997; Kubbutat et al. 1997).”
BackgroundDérijard, B., Hibi, M., Wu, I.-H., Barrett, T., Su, B., Deng, T., Karin, M., & Davis, R. J. (1994) · Cell · doi:10.1016/0092-8674(94)90380-8 · Cited by 3,188
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
Self-citationA Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. (1995) · Science · doi:10.1126/science.7792600 · Cited by 2,785
Hartwell, L. H., & Kastan, M. B. (1994) · Science · doi:10.1126/science.7997877 · Cited by 2,539
Self-citationp53: puzzle and paradigm.Preprint
Ko, L. J., & Prives, C. L. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,346
Flagged first, then by citations
14 of the 71 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 815
Expression and Maintenance of Mitochondrial DNA
Shadel, G. S. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.071163 · Cited by 122
Turenne, G. A., Paul, P., Laflair, L., & Price, B. D. (2001) · Oncogene · doi:10.1038/sj.onc.1204665 · Cited by 120
Woo, R. A., Jack, M. T., Xu, Y., Burma, S., Chen, D. J., & Lee, P. W. K. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf307 · Cited by 122
Li, L., Sharipo, A., Chaves‐Olarte, E., Masucci, M. G., Levitsky, V., Thelestam, M., & Frisan, T. (2002) · Cellular Microbiology · doi:10.1046/j.1462-5822.2002.00174.x · Cited by 119
A Small-Molecule Inhibitor of MDMX Activates p53 and Induces Apoptosis
Wang, H., Ma, X., Ren, S., Buolamwini, J. K., & Yan, C. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0581 · Cited by 117
Kamijo, T., van de Kamp, E. H., Chong, M. J., Zindy, F., Diehl, J. A., Sherr, C. J., & McKinnon, P. J. (1999) · PubMed · Cited by 117
Fox, D. K., Ebert, S. M., Bongers, K. S., Dyle, M. C., Bullard, S. A., Dierdorff, J. M., Kunkel, S. D., & Adams, C. M. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00010.2014 · Cited by 125
Body language: the function of PML nuclear bodies in apoptosis regulation
Hofmann, T. G., & Will, H. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401313 · Cited by 121
DNA-dependent Acetylation of p53 by the Transcription Coactivator p300
Dornan, D., Shimizu, H., Perkins, N. D., & Hupp, T. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211460200 · Cited by 120
Homologous Recombination Deficiencies and Hereditary Tumors
Yamamoto, H., & Hirasawa, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010348 · Cited by 128
Recruitment of ATM Protein to Double Strand DNA Irradiated with Ionizing Radiation
Suzuki, K., Kodama, S., & Watanabe, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25571 · Cited by 115
Achanta, G., Pelicano, H., Feng, L., Plunkett, W. K., & Huang, P. (2001) · PubMed · Cited by 115
Role of homologous recombination in carcinogenesis
Bishop, A. J. R., & Schiestl, R. H. (2003) · Experimental and Molecular Pathology · doi:10.1016/s0014-4800(03)00010-8 · Cited by 114
Alaiya, A. A., Franzén, B., Auer, G., & Linder, S. T. (2000) · Electrophoresis · doi:10.1002/(sici)1522-2683(20000401)21:6 · Cited by 114
HIV-1 Vpr: Mechanisms of G2 arrest and apoptosis
Andersen, J. L., Rouzic, E. L., & Planelles, V. (2008) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2008.03.015 · Cited by 120
The transcriptional activities of p53 and its homologue p51/p63: similarities and differences.
Shimada, A., Kato, S., Enjo, K., Osada, M., Ikawa, Y., Kohno, K., Obinata, M., Kanamaru, R., Ikawa, S., & Ishioka, C. (1999) · PubMed · Cited by 113
Viallard, J.-F., Lacombe, F., Belloc, F., Pellegrin, J., & Reiffers, J. J. (2001) · Cancer/Radiothérapie · doi:10.1016/s1278-3218(01)00087-7 · Cited by 123
Histone Deacetylase Regulation of ATM-Mediated DNA Damage Signaling
Thurn, K. T., Thomas, S., Raha, P., Qureshi, I., & Münster, P. N. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-1242 · Cited by 108
The Mammalian Cell Cycle: An Overview
Harper, J. V., & Brooks, G. (2004) · Humana Press eBooks · doi:10.1385/1-59259-857-9:113 · Cited by 112
Activation of p53 by oncogenes.
Lowe, S. W. (1999) · Endocrine Related Cancer · doi:10.1677/erc.0.0060045 · Cited by 117
Ljungman, M. E., & Paulsen, M. T. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12306-1 · Cited by 107
Thelestam, M. (2004) · Springer eBooks · doi:10.1007/s10254-004-0030-8 · Cited by 106
Offer, H., Erez, N., Zurer, I., Tang, X., Milyavsky, M., Goldfinger, N., & Rotter, V. (2002) · Carcinogenesis · doi:10.1093/carcin/23.6.1025 · Cited by 112
Stewart, G. S., Last, J. I. K., Stanković, T., Kingsbury, N., Kidd, A., Byrd, P. J., & Taylor, A. M. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103160200 · Cited by 107
Cleavage and Inactivation of ATM during Apoptosis
Smith, G. C. M., di Fagagna, F. D., Lakin, N. D., & Jackson, S. P. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.6076 · Cited by 106
Integrative genomic analysis reveals widespread enhancer regulation by p53 in response to DNA damage
Younger, S. T., Kenzelmann-Broz, D., Jung, H., Attardi, L. D., & Rinn, J. L. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv284 · Cited by 99
Wang, H., Chou, W., Shieh, S.-Y., & Shen, C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3270 · Cited by 109
Cao, C., Lü, S., Kivlin, R., Wallin, B., Card, E., Bagdasarian, A., Tamakloe, T., Chu, W., Guan, K., & Wan, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804144200 · Cited by 104
RetractedJiang, C., Hu, H., Malewicz, B., Wang, Z., & Lü, J. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.877.3.7 · Cited by 104
Nucleophosmin Sets a Threshold for p53 Response to UV Radiation
Maiguel, D. A., Jones, L., Chakravarty, D., Yang, C., & Carrier, F. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.9.3703-3711.2004 · Cited by 105
Menon, V., & Povirk, L. F. (2014) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-017-9211-0_17 · Cited by 105
4-Hydroxynonenal induces p53-mediated apoptosis in retinal pigment epithelial cells
Sharma, A., Sharma, R., Chaudhary, P., Vatsyayan, R., Pearce, V., Jeyabal, P., Zimniak, P., Awasthi, S., & Awasthi, S. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.09.016 · Cited by 106
Self-regulatory role of 4-hydroxynonenal in signaling for stress-induced programmed cell death
Awasthi, S., Sharma, R., Sharma, A., Yadav, S., Singhal, S. S., Chaudhary, P., & Awasthi, S. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.04.007 · Cited by 101
Khan, S. H., Moritsugu, J., & Wahl, G. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3266 · Cited by 103
Sumoylation of Mdm2 by Protein Inhibitor of Activated STAT (PIAS) and RanBP2 Enzymes
Miyauchi, Y., Yogosawa, S., Honda, R., Nishida, T., & Yasuda, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208319200 · Cited by 102
Stefano, V. D., Rinaldo, C., Sacchi, A., Soddu, S., & D’Orazi, G. (2003) · Experimental Cell Research · doi:10.1016/j.yexcr.2003.09.032 · Cited by 103
Tumor Suppressor p53 Is Required To Modulate BRCA1 Expression
Arizti, P., Li, F., Park, I., Yin, Y., Solomon, E., Ouchi, T., Aaronson, S. A., & Lee, S. W. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.20.7450-7459.2000 · Cited by 102
Klochendler‐Yeivin, A., Pikarsky, E., & Yaniv, M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.7.2661-2674.2006 · Cited by 104
Deriano, L. (2005) · Blood · doi:10.1182/blood-2004-07-2888 · Cited by 99
Xu, J., & Morris, G. F. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.12 · Cited by 102
Questioning the Role of Checkpoint Kinase 2 in the p53 DNA Damage Response
Ahn, J., Urist, M., & Prives, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213185200 · Cited by 99
Redox Activation of p21 Cip1/WAF1/Sdi1 : A Multifunctional Regulator of Cell Survival and Death
O’Reilly, M. A. (2004) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.108 · Cited by 98
Gadd45a contributes to p53 stabilization in response to DNA damage
Jin, S., Mazzacurati, L., Zhu, X., Tong, T., Song, Y., Shao, S., Petrik, K. L., Rajasekaran, B., Wu, M., & Zhan, Q. (2003) · Oncogene · doi:10.1038/sj.onc.1206907 · Cited by 99
Blanco, S., Klimčáková, L., Vega, F. M. D. L., & Lazo, P. A. (2006) · FEBS Journal · doi:10.1111/j.1742-4658.2006.05256.x · Cited by 95
Zeng, X., Li, X., Miller, A., Yuan, Z.-M., Yuan, W., Kwok, R. P. S., Goodman, R. H., & Lu, H. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.4.1299-1310.2000 · Cited by 97
Role for p300 in Stabilization of p53 in the Response to DNA Damage
Yuan, Z.-M., Huang, Y., Ishiko, T., Nakada, S., Utsugisawa, T., Shioya, H., Utsugisawa, Y., Yokoyama, K. K., Weichselbaum, R. R., Shi, Y., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.4.1883 · Cited by 97
Agarwal, S., Bell, C. M., Rothbart, S. B., & Moran, R. G. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.665133 · Cited by 97
Li, D. W.-C., Liu, J.-P., Schmid, P. C., Schlosser, R., Feng, H., Liu, W.-B., Yan, Q., Gong, L., Sun, S.-M., Deng, M., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209334 · Cited by 98
Functional role of Mdm2 phosphorylation by ATR in attenuation of p53 nuclear export
Shinozaki, T., Nota, A., Taya, Y., & Okamoto, K. (2003) · Oncogene · doi:10.1038/sj.onc.1207176 · Cited by 93
Cisplatinum and Taxol Induce Different Patterns of p53 Phosphorylation
Damia, G. L. M., Filiberti, L., Vikhanskaya, F., Carrassa, L., Taya, Y., D’Incalci, M., & Broggini, M. (2001) · Neoplasia · doi:10.1038/sj.neo.7900122 · Cited by 96
Self-citationSivasubramaniam, S., Sun, X., Pan, Y.-R., Wang, S., & Lee, E. Y.-H. P. (2008) · Genes & Development · doi:10.1101/gad.1627708 · Cited by 97
Wood, L. D., Halvorsen, T. L., Dhar, S., Baur, J. A., Pandita, R. K., Wright, W. E., Hande, M. P., Calaf, G., Hei, T. K., Levine, F., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204072 · Cited by 91
Fornace, A. J., Amundson, S. A., Bittner, M. L., Myers, T. G., Meltzer, P. S., Weinsten, J. N., & Trent, J. M. (1999) · Europe PMC (PubMed Central) · Cited by 90
Early Single Cell Bifurcation of Pro- and Antiapoptotic States during Oxidative Stress
Nair, V. D., Yuen, T., Olanow, C. W., & Sealfon, S. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312135200 · Cited by 90
Rokudai, S., Aikawa, Y., Tagata, Y., Tsuchida, N., Taya, Y., & Kitabayashi, I. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805101200 · Cited by 95
Self-citationEnk, C. D., Jacob–Hirsch, J., Gal, H., Verbovetski, I., Amariglio, N., Mevorach, D., Ingber, A., Givol, D., Rechavi, G., & Hochberg, M. (2006) · Oncogene · doi:10.1038/sj.onc.1209292 · Cited by 92
The cytolethal distending toxins induce DNA damage and cell cycle arrest
Cortes-Bratti, X., Frisan, T., & Thelestam, M. (2001) · Toxicon · doi:10.1016/s0041-0101(01)00159-3 · Cited by 88
Phosphorylation of Sp1 in Response to DNA Damage by Ataxia Telangiectasia-Mutated Kinase
Olofsson, B. A., Kelly, C. M., Kim, J., Hornsby, S. M., & Azizkhan‐Clifford, J. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0374 · Cited by 89
Protein arginine methylation: an emerging regulator of the cell cycle
Raposo, A. E., & Piller, S. C. (2018) · Cell Division · doi:10.1186/s13008-018-0036-2 · Cited by 91
Huang, J., Yang, J., Maity, B., Mayuzumi, D., & Fisher, R. A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3397 · Cited by 86
Role of p53 in cell cycle regulation and apoptosis following exposure to proteasome inhibitors.
Chen, F., Chang, D., Goh, M., Klibanov, S. A., & Ljungman, M. E. (2000) · PubMed · Cited by 87
Homologous recombination as a mechanism for genome rearrangements: environmental and genetic effects
Bishop, A. J. R. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.16.2427 · Cited by 86
Accumulation of soluble and nucleolar-associated p53 proteins following cellular stress
Klibanov, S. A., O’Hagan, H. M., & Ljungman, M. E. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.10.1867 · Cited by 88
Kapoor, M., Hamm, R. L., Yan, W., Taya, Y., & Lozano, G. (2000) · Oncogene · doi:10.1038/sj.onc.1203300 · Cited by 86
Self-citationMDM2 Inhibits PCAF (p300/CREB-binding Protein-associated Factor)-mediated p53 Acetylation
Jin, Y., Zeng, S. X., Dai, M., Yang, X., & Lu, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204078200 · Cited by 86
Glioma oncoprotein Bcl2L12 inhibits the p53 tumor suppressorPreprint
Stegh, A. H., Brennan, C., Mahoney, J. E., Forloney, K. L., Jenq, H. T., Luciano, J. P., Protopopov, A. I., Chin, L., & DePinho, R. A. (2010) · Genes & Development · doi:10.1101/gad.1924710 · Cited by 88
Suppression of cell transformation and induction of apoptosis by caffeic acid phenethyl ester
Nomura, M., Kaji, A., Ma, W., Miyamoto, K., & Dong, Z. (2001) · Molecular Carcinogenesis · doi:10.1002/mc.1043 · Cited by 84
DNA Damage Induces p53-dependent BRCA1 Nuclear Export
Feng, Z., Kachnic, L. A., Zhang, J., Powell, S. N., & Xia, F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404137200 · Cited by 85
Ser392 Phosphorylation Regulates the Oncogenic Function of Mutant p53
Yap, D., Hsieh, J.-K., Zhong, S., Heath, V., Gusterson, B. A., Crook, T., & Lü, X. (2004) · Cancer Research · doi:10.1158/0008-5472.can-1305-2 · Cited by 84
Hagemeier, S. R., Barlow, E. A., Meng, Q., & Kenney, S. C. (2012) · Journal of Virology · doi:10.1128/jvi.01850-12 · Cited by 86
Fraser, M. E., Chan, S., Chan, S. S. L., Fiscus, R. R., & Tsang, B. K. (2005) · Oncogene · doi:10.1038/sj.onc.1209251 · Cited by 82
Kim, K., Dimitrova, D. D., Carta, K. M., Saxena, A. D., Daras, M., & Borowiec, J. A. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.6.2463-2474.2005 · Cited by 86
Luciani, M. G., Campregher, C., Fortune, J. M., Kunkel, T. A., & Gasché, C. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.10.016 · Cited by 80
Nitric oxide induces phosphorylation of p53 and impairs nuclear export
Schneiderhan‐Marra, N., Budde, A., Zhang, Y., & Brüne, B. (2003) · Oncogene · doi:10.1038/sj.onc.1206431 · Cited by 80
The ubiquitin–proteasome system regulates p53-mediated transcription at p21waf1 promoter
Zhu, Q., Wani, G., Yao, J., Patnaik, S., Wang, Q.-E., El-Mahdy, M., Praetorius-Ibba, M., & Wani, A. (2007) · Oncogene · doi:10.1038/sj.onc.1210191 · Cited by 77
Balakrishnan, K., Nimmanapalli, R., Ravandi, F., Keating, M. J., & Gandhi, V. V. (2006) · Blood · doi:10.1182/blood-2006-03-007468 · Cited by 79
Defective homologous recombination in human cancers
Cerbinskaite, A., Mukhopadhyay, A., Plummer, E. R., Curtin, N. J., & Edmondson, R. J. (2011) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2011.04.015 · Cited by 79
Activation of DNA damage response pathways as a consequence of anthracycline-DNA adduct formation
Forrest, R. A., Swift, L. P., Rephaeli, A., Nudelman, A., Kimura, K., Phillips, D. R., & Cutts, S. M. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.02.026 · Cited by 82
What have animal models taught us about the p53 pathway?
Lozano, G., & Zambetti, G. P. (2005) · The Journal of Pathology · doi:10.1002/path.1704 · Cited by 78
Atm deficiency causes an increased frequency of intrachromosomal homologous recombination in mice.
Bishop, A. J. R., Barlow, C., Wynshaw-Boris, A. J., & Schiestl, R. H. (2000) · PubMed · Cited by 75
Homologous Recombination and Its Role in Carcinogenesis
Bishop, A. J. R., & Schiestl, R. H. (2002) · BioMed Research International · doi:10.1155/s1110724302204052 · Cited by 77
30 years and a long way into p53 research
Hainaut, P. L., & Wiman, K. G. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70198-6 · Cited by 80
Regulation of TIP60 by ATF2 Modulates ATM Activation
Bhoumik, A., Singha, N. C., O’Connell, M. J., & Ronai, Z. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802030200 · Cited by 80
Keller, D., Zeng, X., Li, X., Kapoor, M., Iordanov, M. S., Taya, Y., Lozano, G., Magun, B. E., & Lu, H. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1023 · Cited by 75
Self-citationDohoney, K. M., Guillerm, C., Whiteford, C. C., Elbi, C., Lambert, P. F., Hager, G. L., & Brady, J. N. (2004) · Oncogene · doi:10.1038/sj.onc.1207005 · Cited by 77
Homologous recombination as a mechanism of carcinogenesis
Bishop, A. J. R., & Schiestl, R. H. (2001) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(01)00018-x · Cited by 76
Dumaz, N., Milne, D., Jardine, L., & Meek, D. W. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3590459 · Cited by 75
RNA content in the nucleolus alters p53 acetylation via MYBBP1A
Kuroda, T., Murayama, A., Katagiri, N., Ohta, Y., Fujita, E., Masumoto, H., Ema, M., Takahashi, S., Kimura, K., & Yanagisawa, J. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.23 · Cited by 77
Role of MAP kinases in UVB-induced phosphorylation of p53 at serine 20
She, Q., Ma, W., & Dong, Z. (2002) · Oncogene · doi:10.1038/sj.onc.1205239 · Cited by 73
Campregher, C., Luciani, M. G., & Gasché, C. (2008) · Gut · doi:10.1136/gut.2007.141556 · Cited by 75
Initiation of eukaryotic DNA replication: Regulation and mechanisms
Nasheuer, H., Smith, R. W., Bauerschmidt, C., Große, F., & Weißhart, K. (2002) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(02)72067-9 · Cited by 76
Melanoma Cells Express Elevated Levels of Phosphorylated Histone H2AX Foci
Warters, R. L., Adamson, P. J., Pond, C. D., & Leachman, S. A. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23674.x · Cited by 77
DNA-dependent Protein Kinase-independent Activation of p53 in Response to DNA Damage
Burma, S., Kurimasa, A., Xie, G., Taya, Y., Araki, R., Abe, M., Crissman, H. A., Ouyang, H., Li, G. C., & Chen, D. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.17139 · Cited by 73
Self-citationDNA damage, p14ARF, Nucleophosmin (NPM/B23), and cancer
Gjerset, R. A. (2006) · Journal of Molecular Histology · doi:10.1007/s10735-006-9040-y · Cited by 71
Castillo, J., Frame, F. M., Rogoff, H. A., Pickering, M., Yurochko, A. D., & Kowalik, T. F. (2005) · Journal of Virology · doi:10.1128/jvi.79.17.11467-11475.2005 · Cited by 72
Shono, T., Tofilon, P. J., Schaefer, T. S., Parikh, D., Liu, T.-J., & Lang, F. F. (2002) · PubMed · Cited by 71
Cytoplasmically “Sequestered” Wild Type p53 Protein Is Resistant to Mdm2-mediated Degradation
Zaika, A. I., Marchenko, N. D., & Moll, U. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.39.27474 · Cited by 72
Paris saponin VII inhibits growth of colorectal cancer cells through Ras signaling pathway
Li, Y., Sun, Y., Fan, L., Zhang, F., Meng, J., Han, J., Guo, X., Zhang, D., Zhang, R., Yue, Z., et al. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.018 · Cited by 71
Knappskog, S., Chrisanthar, R., Løkkevik, E., Anker, G. B., Østenstad, B., Lundgren, S., Risberg, T., Mjaaland, I., Leirvaag, B., Miletić, H., et al. (2012) · Breast Cancer Research · doi:10.1186/bcr3147 · Cited by 71
ATM&A Key Determinant of Multiple Cellular Responses to Irradiation
Kastan, D.-S. L. M. B. (2001) · Acta Oncologica · doi:10.1080/02841860152619089 · Cited by 70
Metadata
- Authors
- Siliciano, J. D., Canman, C. E., Taya, Y., Sakaguchi, K., Appella, E., & Kastan, M. B.
- Affiliations
- National Institutes of Health (US)
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 1997-12-15
- Volume
- 11
- Issue
- 24
- Pages
- 3471-3481
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- PMC
- PMC316806
- OpenAlex
- W2149013144
- Cited by
- 818
- References
- 71
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 5 · 2023: 7 · 2022: 10 · 2021: 10 · 2020: 12 · 2019: 14 · 2018: 12 · 2017: 18 · 2016: 22 · 2015: 17 · 2014: 24 · 2013: 21 · 2012: 27
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- American Society of Hematology
- National Institutes of Health (ES05777)
- National Cancer Institute (CA71387, R01CA071387)
- National Institute of Environmental Health Sciences (R01ES005777, R37ES005777, ES05777)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- p53, DNA damage response, ionizing radiation, UV irradiation, post-translational modification, ATM kinase, lymphoblasts
- MeSH terms
- Ataxia Telangiectasia, Binding Sites, Cells, Cultured, DNA, DNA Damage, Electrophoresis, Humans, Lymphocytes, Nuclear Proteins, Peptide Fragments, Phosphorylation, Protein Processing, Post-Translational, Proto-Oncogene Proteins, Serine, Ultraviolet Rays, Signal Transduction, Tumor Suppressor Protein p53, Cyclins, Cyclin-Dependent Kinase Inhibitor p21, Proto-Oncogene Proteins c-mdm2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review